Worldwide, over 40 million people have dementia due to Alzheimer’s disease and some 100 million older adults are estimated to be at increased risk (preclinical disease) for future dementia. Stem cells hold great promise for regenerating neural tissue, disease modeling and drug discovery but also raise new questions for regulators, ethicists, scientists, physicians and industry. Join us for this exciting workshop, featuring some of the nation’s leading experts, to discuss these exciting new developments.  

Distinguished Duke Alumnae Leader and Philanthropist: Marjorie Bekaert Thomas

Keynote address: Mahendra Rao, MD, PhD

Distinguished Speakers: Anthony Atala, MD · Jeff Bulte, PhD · Alexandra Capela, PhD · Stephen Chang, PhD · Eva Chmielnicki, PhD · P. Murali Doraiswamy, MBBS, FRCP · Ellen Fiegal, MD · Thomas Finn, PhD · Hank Greely, JD · Larry Goldstein, PhD · Chris Henderson, PhD · Joanne Kurtzberg, MD · Frank LaFerla, PhD · Akira Sawa, MD, PhD · Lon Schneider, MD · Ajay Verma, MD, PhD

The conference is supported by The Karen L. Wrenn Family Trust; Duke Department of Psychiatry and Behavioral Sciences; Robertson Clinical and Translational Cell Therapy Program at Duke; and the NIH Center for Regenerative Medicine.

The Kitty Wrenn Family Trust
Neurocognitive Disorders Program, Department of Psychiatry and Behavioral Sciences
Robertson Clinical and Translational Cell Therapy Program
NIH Center for Regenerative Medicine